BIK and infection: To assess the therapeutic potential of BIK silencing in the airways, we instilled WT C57BL/6 mice with retroviral vectors expressing either control shRNA (shCtr) or shRNA targeting BIK (shBIK) intranasally 2 d prior to infection with a lethal dose of PR/8 (SI Appendix, Fig. S3A).